Christopher E. Walsh, MD, PhD
Associate Professor of Medicine, Division of Hematology and Medical Oncology
Icahn School of Medicine at Mount Sinai
Director, Hemophilia Treatment Center, Mount Sinai Hospital
New York, NY


Margaret V. Ragni, MD, MPH
Professor of Medicine and Clinical Translational Science
Department of Medicine, Division of Hematology/Oncology
University of Pittsburgh Medical Center 
Director, Hemophilia Center of Western PA
Pittsburgh, PA 

Guy A. Young, MD 
Professor of Pediatrics – Clinical Scholar 
Keck School of Medicine 
University of Southern California
Director, Hemostasis and Thrombosis Program
Children's Hospital of Los Angeles
Los Angeles, CA 

By the end of this session, the participant should be better able to:

  • Describe the emerging therapies and novel non-factor approaches in development for treating patients with hemophilia A and B.
  • Summarize the latest clinical trial data available on new and emerging therapies.